Advertisement

FDA Approves Ajovy for Migraine Prevention in Children and Teens

0

Approval is for children and adolescents aged 6 to 17 years weighing ≥45 kg

Cognitive Functional Therapy Effective for Chronic Low Back Pain at Three Years

0

Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain

FDA Requiring Stronger Safety Labels for Opioid Medications

0

Updated opioid safety labeling is based on new data from two large postmarketing observational studies

Perioperative Counseling Reduces Opioid Use After ACL Reconstruction Surgery

0

Authors say patients should be counseled to take opioids as a 'last resort' to manage pain, not to 'stay ahead of the pain'

Remote CBT-Based Therapy Yields Modest Improvements in Chronic Pain

0

Both telehealth and self-completed online intervention groups more likely to attain clinically important difference in pain severity versus usual care

Increase Seen in Reports of Lidocaine Poisonings and Mortality Since 2010

0

Following publication of advisories, reports of local anesthetic poisoning decreased, but reports of lidocaine poisoning and mortality increased

Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department

0

Opioids administered or prescribed in 35.0 and 32.5 percent of U.S. visits in 2016, respectively, compared with 24.5 and 13.5 percent in 2022

Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI

0

Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions

Health Care Expenditure Expected to Top GDP Growth 2024 to 2033

0

National health care expenditure growth expected to outpace GDP, resulting in a health share of GDP that reaches 20.3 percent by 2033

Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine

0

Decrease seen in mean monthly headache days and reduction in Migraine Disability Assessment scores